Profile
DXR ISRG BDX BDXA ALC RMD
Company Name Daxor Corporation Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $61.52M $173.36B $59.94B $55.91B $39.26B $37.85B
Employees 0.04K 15.64K 70.00K 0.00K 25.60K 9.98K
CEO Michael Richard Feldschuh David J. Rosa Thomas E. Polen Jr. - David J. Endicott Michael J. Farrell
Ratings
DXR ISRG BDX BDXA ALC RMD
Quant Rating Score 3 1 3 5 3 4
Quant Rating Neutral Strong Sell Neutral Strong Buy Neutral Buy
Trading
DXR ISRG BDX BDXA ALC RMD
Last Close $12.944 $546.71 $190.98 $59.24 $76.61 $244.71
High 52 $14.18 $610.45 $249.08 $59.24 $98.3 $293.73
Low 52 $7.05 $429.59 $165.15 $59.24 $72.05 $204.58
Price vs. 52 Week High -8.72 % -10.44 % -23.33 % 0 % -22.07 % -16.69 %
Price vs. 52 Week Low 83.6 % 27.26 % 15.64 % 0 % 6.33 % 19.62 %
Total Return
DXR ISRG BDX BDXA ALC RMD
1 Month Return -0.01 % 22.54 % 0.99 % 0 % 2 % -8.72 %
3 Month Return 17.46 % 13.64 % -2.06 % 0 % -13.07 % -14.47 %
6 Month Return 69.03 % -3 % 8.88 % 0 % -14.72 % -2.77 %
9 Month Return 79.03 % -9.02 % -15.17 % 0 % -14.35 % 6.13 %
YTD Return 68.32 % 4.74 % -15.82 % 0 % -9.75 % 7.01 %
1 Year Return 43.98 % 1.46 % -14.22 % 0 % -10.32 % 2.77 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DXR ISRG BDX BDXA ALC RMD
Dividend Yield Percentage (TTM) - - 1.99 % 2.02 % 0.42 % 0.87 %
Dividend Paid and Capex Coverage Ration (TTM) -35008 % 4.3 % 1.75 % 1.75 % 3.02 % 4.31 %
Dividend Per Share (TTM) - - 4.17 % 4.17 % 0.33 % 2.26 %
Payout Ratio (TTM) - - 71.28 % 71.28 % 15.49 % 22.31 %
Profitability
DXR ISRG BDX BDXA ALC RMD
Gross Profit Margin TTM 89.54 % 66.06 % 45.44 % 45.44 % 55.12 % 60.08 %
Return on Assets TTM 5.01 % 14.76 % 3.03 % 3.03 % 3.32 % 17.31 %
Return on Equity TTM 5.03 % 16.72 % 6.63 % 6.63 % 4.77 % 25.13 %
Return on Capital Employed TTM 5.39 % 16.78 % 5.48 % 5.48 % 5.06 % 24.74 %
Net Income Per EBT TTM 100 % 86.25 % 89.16 % 89.16 % 84.1 % 82.6 %
EBT Per Ebit TTM 92.85 % 112.42 % 73 % 73 % 86.34 % 99.79 %
EBIT Per Revenue TTM 271.25 % 29.27 % 11.8 % 11.8 % 14.16 % 33.18 %
Cash Flow To Debt Ratio TTM -13.31 % - 17.88 % 17.88 % 39.18 % 222.53 %
Receivables Turnover TTM 393.63 7.27 7.29 7.29 5.26 5.49
Payables Turnover TTM 7.86 11.73 - - 5.11 7.87
Inventory Turnover TTM - 1.92 3.06 3.06 1.88 2.22
Fixed Asset Turnover TTM - 195.4 % 312.12 % 312.12 % 198.09 % 724.52 %
Asset Turnover TTM 1.99 % 52.01 % 39.47 % 39.47 % 32.34 % 63.28 %
Operating Cash Flow Per Share TTM -0.01 8.34 11.97 11.97 4.16 12.86
Free Cash Flow Per Share TTM -0.01 6.4 9.32 9.32 3.11 12.06
Cash Per Share TTM - 1383.15 % 299.71 % 299.71 % 303.41 % 944.79 %
Operating Cash Flow Sales Ratio TTM -4.91 % 29.42 % 15.71 % 15.71 % 20.13 % 35.82 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.01 % 76.72 % 77.84 % 77.84 % 74.75 % 93.83 %
Cash Flow Coverage Ratios TTM -13.31 % - 17.88 % 17.88 % 39.18 % 222.53 %
Price To Free Cash Flows Ratio TTM -1757.21 76.32 22.45 22.08 25.61 21.42
Price To Operating Cash Flows Ratio TTM -1738.48 58.52 17.55 17.26 19.09 20.16
Price Cash Flow Ratio TTM -1738.48 58.52 17.55 17.26 19.09 20.16
Income Statement (TTM)
DXR ISRG BDX BDXA ALC RMD
Revenue $0B $10.06B $21.84B $21.84B $9.91B $5.15B
Gross Profit $0B $6.66B $9.92B $9.92B $5.51B $3.05B
Gross Profit Ratio 100% 66.13% 45.44% 45.44% 55.61% 59.36%
EBITDA $0B $3.31B $4.96B $4.96B $2.68B $1.91B
Net Income $0B $2.86B $1.68B $1.68B $1.02B $1.4B
EPS Diluted 0.11 7.87 5.83 5.83 2.05 9.51
Balance Sheet (MRQ)
DXR ISRG BDX BDXA ALC RMD
Long Term Debt $0B $0.11B $17.62B $17.62B $4.97B $0.81B
Total Liabilities $0B $2.31B $29.94B $29.94B $8.79B $2.21B
Total Equity $0.04B $16.53B $25.39B $25.39B $21.55B $5.97B
Total Investments $0.04B $7.05B $0.01B $0.01B $0.91B $0.09B
Total Debt $0B $0.15B $19.18B $19.18B $5.14B $0.85B
Total Assets $0.04B $18.84B $55.33B $55.33B $30.35B $8.17B
Cash Flow Statement (TTM)
DXR ISRG BDX BDXA ALC RMD
Net Income $0B $2.34B $1.68B $1.68B $1.02B $1.4B
Inventory $0B $-0.83B $-0.41B $-0.41B $-0.05B $-0.08B
Dividends Paid $0B $0B $-1.2B $-1.2B $-0.13B $-0.31B
Operating Cash Flow $0B $2.42B $3.43B $3.43B $2.08B $1.75B
Capital Expenditure $0B $-1.11B $-0.76B $-0.76B $-0.67B $-0.09B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 78.83
ANGO AngioDynamics, Inc. 10.56
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 134.31
ATRC AtriCure, Inc. 37.11
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AVTR Avantor, Inc. 11.26
AZTA Azenta, Inc. 28.72
BAX Baxter International Inc. 21.73
BDX Becton, Dickinson and Company 210.02
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 17
BLFS BioLife Solutions, Inc. 22.43
COO The Cooper Companies, Inc. 82.1
EKSO Ekso Bionics Holdings, Inc. 10.41
FEMY Femasys Inc. 0.508
ETFs With Exposure to DXR
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00003 340.96
VUN.TO Vanguard U.S. Total Market Index ETF 0.00003 126.63
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00003 118.21
VGRO.TO Vanguard Growth ETF Portfolio 0.00001 44.01
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00002 55.34
VBAL.TO Vanguard Balanced ETF Portfolio 0.00001 37.61
VCNS.TO Vanguard Conservative ETF Portfolio 0.00001 31.94
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.22
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 26.82
VTSAX Vanguard Total Stock Market Index Fund 0.00003 166.03
VITSX Vanguard Total Stock Market Index Fund 0.00003 166.06
VTS.AX Vanguard US Total Market Shares Index ETF 0.00003 479.23
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00003 311.51
Unlock